Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vagal Nerve Stimulation in mTBI

NCT: NCT04437498 · RECRUITING

NCT IDNCT04437498
StatusRECRUITING
Start Date2021-02-25
Completion2026-12-10
SponsorVA Office of Research and Development (FED)
First posted
Last updated

Brief Summary

Mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) are important conditions for the Veterans Administration (VA) that frequently occur together in combat Veterans from the conflicts in Afghanistan and Iraq. In many Veterans these become chronic, raising the risk the burden of neurotrauma can worsen over time. This study will examine a new intervention called non-invasive Vagal Nerve Stimulation (nVNS) and its effects on memory and symptoms of PTSD and mTBI as well as brain and physiology in Veterans with mTBI and PTSD.

Frequently Asked Questions

What is Vagal Nerve Stimulation in mTBI?

Vagal Nerve Stimulation in mTBI is a clinical trial registered under NCT04437498. Current status: RECRUITING.

What is the status of NCT04437498?

The current status of NCT04437498 (Vagal Nerve Stimulation in mTBI) is: RECRUITING.

When did Vagal Nerve Stimulation in mTBI start?

Vagal Nerve Stimulation in mTBI started on 2021-02-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑